Enliven Therapeutics shares owned by Vanguard Capital Management
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Vanguard Capital Management
from 13F filings
Historical chart of Vanguard Capital Management investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by Vanguard Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enliven Therapeutics by Vanguard Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $130M | 2.6M | 50.75 |
| 2026-03-31 | $85M | 2.2M | 39.20 |